Silverback Therapeutics, Inc.
NECTIN-4 ANTIBODY CONJUGATES AND USES THEREOF
Last updated:
Abstract:
The present disclosure provides conjugates of anti-Nectin-4 antibodies or antigen binding fragments thereof to a myeloid cell agonist, compositions comprising the conjugates, and methods of treating cancer with the conjugates. The present disclosure also provides for anti-Nectin-4 antibodies or antigen binding fragments thereof and method for using the antibodies or antigen binding fragments thereof in treating cancer.
Status:
Application
Type:
Utility
Filling date:
4 Oct 2021
Issue date:
7 Apr 2022